INNO LASER(301021)
Search documents
英诺激光(301021) - 关于参加2021深圳辖区上市公司投资者网上集体接待日活动的公告
2021-11-26 08:04
证券代码:301021 证券简称:英诺激光 公告编号:2021-035 英诺激光科技股份有限公司 关于参加2021深圳辖区上市公司投资者网上 集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有 虚假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,英诺激光科技股份有限公司(以下简称 "公司")将参加由深圳上市公司协会、深圳市全景网络有限公司共同举办的 "沟通传递价值,交流创造良好生态"——2021 深圳辖区上市公司投资者网上集 体接待日活动,现将有关事项公告如下: 本次集体接待日活动将在深圳市全景网络有限公司提供的网上平台,采取网 络远程的方式举行,投资者可以关注微信公众号:全景财经,或登录"全景•路演 天下"网站(http://rs.p5w.net/),参与公司本次投资者集体接待日活动,活动 时间为 2021 年 11 月 30 日 14:00 至 17:00,其中公司与投资者网上互动时间为 15:30 至 17:00。 届时公司的主要高级管理人员将通过网络文字交流形式与投资者进行沟通。 欢迎广大投资者积极参与。 特此公告。 英诺激光科技股份有限公司董事会 20 ...
英诺激光(301021) - 2021 Q3 - 季度财报
2021-10-28 16:00
Financial Performance - The company's revenue for Q3 2021 reached ¥91,385,219.87, representing a 10.97% increase year-over-year, while the year-to-date revenue increased by 36.30% to ¥294,103,293.38[4] - Net profit attributable to shareholders for Q3 2021 was ¥25,838,105.67, an increase of 88.96% compared to the same period last year, with a year-to-date net profit of ¥66,296,335.71, up 125.49%[4] - The basic earnings per share for Q3 2021 was ¥0.1704, reflecting a 41.62% increase year-over-year, and the year-to-date figure was ¥0.5249, up 102.90%[5] - Total revenue for Q3 2021 reached ¥294,103,293.38, an increase of 36.3% compared to ¥215,772,675.44 in Q3 2020[25] - Operating profit for Q3 2021 was ¥73,461,293.23, significantly higher than ¥29,515,198.07 in Q3 2020, marking a year-over-year increase of 148.5%[25] - The net profit for Q3 2021 was CNY 66,737,215.79, a significant increase of 127.5% compared to CNY 29,327,371.75 in Q3 2020[26] - The basic and diluted earnings per share for Q3 2021 were both CNY 0.5249, up from CNY 0.2587 in the same period last year, representing a growth of 103.5%[26] - The company reported a total comprehensive income of CNY 66,507,216.96 for Q3 2021, compared to CNY 27,968,474.80 in Q3 2020, reflecting a growth of 137.5%[26] Assets and Liabilities - Total assets as of September 30, 2021, amounted to ¥1,103,485,150.19, a 37.75% increase from the end of the previous year, while equity attributable to shareholders increased by 63.23% to ¥966,856,318.40[5] - Total assets as of the end of Q3 2021 were CNY 801,052,827.50, reflecting a strong asset base for future growth[30] - Current assets totaled ¥842,311,363.17 as of September 30, 2021, an increase of 52.5% from ¥551,778,259.93 at the end of 2020[22] - Total liabilities decreased to ¥135,376,108.20 from ¥207,896,758.98, a reduction of 34.8%[23] - Shareholders' equity increased to ¥968,109,041.99 from ¥593,156,068.52, reflecting a growth of 63.3%[23] - Total liabilities reached ¥207,896,758.98, down by ¥6,096,180.08 from the last reporting period[33] - Current liabilities totaled ¥171,717,011.15, reflecting a decrease of ¥4,656,284.73[33] - Non-current liabilities were reported at ¥36,179,747.83, a decrease of ¥1,439,895.35[33] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥17,593,732.88, showing a decrease of 33.04% compared to the previous year[4] - Cash flow from operating activities generated a net cash inflow of CNY 17,593,732.88, down 33.1% from CNY 26,274,317.28 in Q3 2020[28] - Total cash and cash equivalents at the end of Q3 2021 reached CNY 415,128,175.28, an increase of 128.5% from CNY 181,809,378.36 at the end of Q3 2020[29] - Cash inflow from financing activities was CNY 379,723,871.85, a substantial increase from CNY 93,535,089.88 in the previous year[29] - The company incurred a net cash outflow from investing activities of CNY 26,697,505.50, compared to a net outflow of CNY 12,016,385.25 in Q3 2020[29] Shareholder Information - The total number of common shareholders at the end of the reporting period is 25,338[15] - The largest shareholder, DeTai International Investment Group Limited, holds 28.08% of shares, totaling 42,580,000 shares[15] - Shenzhen Hongcui Investment Enterprise (Limited Partnership) is the second-largest shareholder with a 25.70% stake, amounting to 38,970,000 shares[15] - The company has a total of 119,217,416 restricted shares at the end of the reporting period[19] - The company has no preferred shareholders as of the reporting date[17] - The total number of restricted shares held by DeTai International Investment Group Limited and Shenzhen Hongcui Investment Enterprise is 81,550,000 shares, which will be released on July 6, 2024[18] - The company reported a total of 1,772,334 shares under offline issuance restrictions[19] - The company has a total of 10,030,000 shares held by Shenzhen Huishang Investment Enterprise (Limited Partnership), which are also restricted[18] - The company has a total of 3,800,000 shares under the management plan of Changcheng Securities and Construction Bank, which are restricted until July 6, 2022[18] Expenses - The company experienced a 50.17% increase in sales expenses, totaling ¥24,310,606.20, attributed to the expansion of sales channels[11] - Research and development expenses for Q3 2021 were ¥38,093,325.71, compared to ¥32,141,904.82 in Q3 2020, an increase of 18.5%[25] Other Information - The company reported a significant increase in other income, which reached ¥24,044,853.87, a 265.16% increase year-over-year, primarily due to government subsidies received[12] - The report for the third quarter was not audited[35] - The company has a capital reserve of ¥233,821,112.89[34] - The undistributed profits amounted to ¥226,541,491.64[34] - The company executed a retrospective adjustment of ¥6,096,180.08 for the right-of-use assets due to the new leasing standards[34]
英诺激光(301021) - 2021 Q2 - 季度财报
2021-08-27 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was ¥202,718,073.51, representing a 51.93% increase compared to ¥133,425,058.48 in the same period last year[20]. - The net profit attributable to shareholders for the first half of 2021 was ¥40,458,230.04, a significant increase of 157.26% from ¥15,726,733.31 in the previous year[20]. - The net profit after deducting non-recurring gains and losses was ¥26,316,406.14, up 124.25% from ¥11,735,298.14 in the same period last year[20]. - The basic earnings per share for the first half of 2021 was ¥0.3560, an increase of 157.23% compared to ¥0.1384 in the previous year[20]. - The company reported a negative net cash flow from operating activities of ¥913,227.11, a decline of 105.13% compared to a positive cash flow of ¥17,794,967.81 in the same period last year[20]. - The weighted average return on equity for the first half of 2021 was 6.60%, an increase of 3.68% from 2.92% in the previous year[20]. - The company's revenue for the reporting period reached ¥202,718,073.51, representing a year-on-year increase of 51.93% due to business expansion and the impact of the pandemic in the previous year[43]. - The gross profit margin for laser products was 52.06%, with a 39.58% increase in revenue compared to the previous year, while the gross profit margin for laser modules was 55.15%[45]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,133,127,666.79, reflecting a 41.45% increase from ¥801,052,827.50 at the end of the previous year[20]. - The net assets attributable to shareholders at the end of the reporting period were ¥940,829,241.23, a 58.84% increase from ¥592,326,455.18 at the end of the previous year[20]. - The total liabilities decreased to ¥176,132,441.54 from ¥219,939,823.04, reflecting a reduction of 20.0%[153]. - Cash and cash equivalents increased significantly to ¥432,441,335.52 from ¥142,417,956.31, marking a growth of 203.0%[151]. - The company's inventory rose to CNY 186,353,775.99, compared to CNY 145,698,946.14 at the end of 2020, marking an increase of approximately 27.8%[146]. - The accounts receivable increased to CNY 175,728,996.08 from CNY 165,369,811.07, which is an increase of about 6.8%[146]. Research and Development - Research and development expenses increased by 23.38% to ¥25,591,581.84, driven by an increase in R&D personnel and new product development[43]. - The company has increased its R&D investment to enhance core technology and product innovation, resulting in multiple invention patents[78]. - The company launched several new laser products, including a 25W UV solid laser with intelligent point-switching capabilities and a high-energy pulsed infrared picosecond laser for cutting transparent materials[30]. - The company plans to focus on the biomedical field as a key development direction, expanding its capabilities in precision drilling and laser micro-welding for medical devices[31]. Market and Competition - The company faces risks related to market competition, with competitors including major firms like Coherent and Trumpf[80]. - The company operates R&D, production, and sales systems in both China and the United States, enhancing its market responsiveness[36]. - The laser processing technology is expected to replace traditional machining methods, providing significant market opportunities for the company[33]. - The company has a diverse customer base across over 20 countries, including the USA, Germany, and Japan, focusing on industries such as consumer electronics and biomedical[41]. Corporate Governance and Shareholder Matters - The company plans not to distribute cash dividends or issue bonus shares for the reporting period[5]. - The company has not encountered any issues regarding the use and disclosure of raised funds as of June 30, 2021[67]. - The company issued 38 million new shares, increasing the total share count from 113.65 million to 151.65 million[124]. - The proportion of shares held by domestic legal entities decreased from 62.53% to 50.53% after the issuance of new shares[124]. - The company was approved for its initial public offering (IPO) on July 6, 2021, and listed on the Shenzhen Stock Exchange[125]. Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[174]. - The management has provided a positive outlook for the second half of 2021, expecting continued revenue growth and profitability improvements[182]. - The company’s future outlook includes potential market expansion and new product development strategies[1].